Stephanie Lodise is co-leader of the firm’s Biotechnology, Chemical and Pharmaceutical Team and a patent attorney with more than 15 years of experience in securing, expanding and maintaining exclusivity for pharmaceuticals in the U.S. and abroad. She focuses on building patent portfolios for both new and re-purposed small molecules, reinforcing mature patent portfolios, analyzing freedom-to-market issues, managing patent office administrative impediments, navigating patent landscapes and developing patent protection for products subject to Hatch-Waxman litigation.
Stephanie's practice focuses on all phases of highly sophisticated patent prosecution and analysis for pharmaceutical and material science clients. Large patent portfolios require adroit management, and Stephanie demonstrates her proficiency by directing the prosecution of complex portfolios both in the U.S. and internationally. Her scientific acumen, advocacy and pragmatism are instrumental in obtaining and maintaining key patent coverage for commercialized and licensed technologies. As one of the few patent lawyers in the country with a Ph.D. in synthetic organic chemistry, as well as experience as a research chemist at a major pharmaceutical company, Stephanie's skills in small molecule design, synthesis, formulation and use are highly valued among many life sciences clients.